These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

82 related items for PubMed ID: 16377010

  • 1. Clinical, biochemical and genetical resistance to clopidogrel in a patient with the recurrent coronary stent thrombosis--a case report and review of the literature.
    Glowczynska R, Malek LA, Spiewak M, Filipiak KJ, Grabowski M, Kisiel B, Kochman J, Kostrzewa G, Ploski R, Opolski G.
    Int J Cardiol; 2006 Aug 10; 111(2):326-8. PubMed ID: 16377010
    [Abstract] [Full Text] [Related]

  • 2. Clopidogrel resistance in diabetic patient with acute myocardial infarction due to stent thrombosis.
    Samoš M, Šimonová R, Kovář F, Duraj L, Fedorová J, Galajda P, Staško J, Fedor M, Kubisz P, Mokáň M.
    Am J Emerg Med; 2014 May 10; 32(5):461-5. PubMed ID: 24560391
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Prasugrel in Clopidogrel Nonresponders Undergoing Percutaneous Coronary Intervention: The RECLOSE-3 Study (REsponsiveness to CLOpidogrel and StEnt Thrombosis).
    Valenti R, Marcucci R, Comito V, Marrani M, Cantini G, Migliorini A, Parodi G, Gensini GF, Abbate R, Antoniucci D.
    JACC Cardiovasc Interv; 2015 Oct 10; 8(12):1563-70. PubMed ID: 26386764
    [Abstract] [Full Text] [Related]

  • 5. Clopidogrel for prevention of major cardiac events after coronary stent implantation: 30-day and 6-month results in patients with smaller stents.
    Calver AL, Blows LJ, Harmer S, Dawkins KD, Gray HH, Morgan JH, Simpson IA.
    Am Heart J; 2000 Sep 10; 140(3):483-91. PubMed ID: 10966552
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Stent thrombosis in a clopidogrel nonresponder.
    Laird PA, Ruppert SD.
    Crit Care Nurs Q; 2012 Sep 10; 35(2):151-9. PubMed ID: 22407371
    [Abstract] [Full Text] [Related]

  • 8. Impaired responsiveness to clopidogrel and aspirin in patients with recurrent stent thrombosis following percutaneous intervention for peripheral artery disease.
    Mazur P, Frołow M, Niżankowski R, Sadowski J, Undas A.
    Platelets; 2013 Sep 10; 24(2):151-5. PubMed ID: 22497730
    [Abstract] [Full Text] [Related]

  • 9. Adjunctive cilostazol versus double-dose clopidogrel after drug-eluting stent implantation: the HOST-ASSURE randomized trial (Harmonizing Optimal Strategy for Treatment of Coronary Artery Stenosis-Safety & Effectiveness of Drug-Eluting Stents & Anti-platelet Regimen).
    Park KW, Kang SH, Park JJ, Yang HM, Kang HJ, Koo BK, Park BE, Cha KS, Rhew JY, Jeon HK, Shin ES, Oh JH, Jeong MH, Kim S, Hwang KK, Yoon JH, Lee SY, Park TH, Moon KW, Kwon HM, Chae IH, Kim HS.
    JACC Cardiovasc Interv; 2013 Sep 10; 6(9):932-42. PubMed ID: 24050860
    [Abstract] [Full Text] [Related]

  • 10. Successful Prasugrel Therapy for Recurrent Left Main Stent Thrombosis in a Clopidogrel Hyporesponder.
    Kim YS, Lee SR.
    Tex Heart Inst J; 2015 Oct 10; 42(5):483-6. PubMed ID: 26504448
    [Abstract] [Full Text] [Related]

  • 11. Prolonged jaundice following percutaneous coronary intervention and ticlopidine therapy.
    Tsui PT, Lai ST, Leung WS, Mok NS, Wu CW, Lau ST, Choi YC.
    Hong Kong Med J; 2002 Feb 10; 8(1):57-9. PubMed ID: 11861996
    [Abstract] [Full Text] [Related]

  • 12. Drug-specific thienopyridine resistance in patient with recurrent coronary stent thrombosis.
    Milicic D, Skoric B, Lovric D.
    J Invasive Cardiol; 2009 Aug 10; 21(8):E157-60. PubMed ID: 19652267
    [Abstract] [Full Text] [Related]

  • 13. Increased long term rates of stent thrombosis and mortality in patients given clopidogrel as compared to ticlopidine following coronary stent implantation.
    Wolak A, Amit G, Cafri C, Gilutz H, Ilia R, Zahger D.
    Int J Cardiol; 2005 Sep 01; 103(3):293-7. PubMed ID: 16098392
    [Abstract] [Full Text] [Related]

  • 14. Clopidogrel resistance?
    Gurbel PA, Tantry US.
    Thromb Res; 2007 Sep 01; 120(3):311-21. PubMed ID: 17109936
    [Abstract] [Full Text] [Related]

  • 15. Clinical, biochemical and genetical resistance to clopidogrel in a patient with recurrent stent thrombosis.
    van Werkum JW, Heestermans AA, Plokker HW, ten Berg JM.
    Int J Cardiol; 2007 Mar 02; 116(1):136-7; author reply 134-5. PubMed ID: 16870279
    [No Abstract] [Full Text] [Related]

  • 16. Stent thrombosis is associated with an impaired response to antiplatelet therapy.
    Wenaweser P, Dörffler-Melly J, Imboden K, Windecker S, Togni M, Meier B, Haeberli A, Hess OM.
    J Am Coll Cardiol; 2005 Jun 07; 45(11):1748-52. PubMed ID: 15936599
    [Abstract] [Full Text] [Related]

  • 17. Clopidogrel "resistance": where are we now?
    Qureshi Z, Hobson AR.
    Cardiovasc Ther; 2013 Feb 07; 31(1):3-11. PubMed ID: 21884029
    [Abstract] [Full Text] [Related]

  • 18. High maintenance dosage of clopidogrel is associated with a reduced risk of stent thrombosis in clopidogrel-resistant patients.
    Tavassoli N, Voisin S, Carrie D, Lapeyre-Mestre M, Galinier M, Montastruc JL, Pathak A.
    Am J Cardiovasc Drugs; 2010 Feb 07; 10(1):29-35. PubMed ID: 20104932
    [Abstract] [Full Text] [Related]

  • 19. Impact of concomitant treatment with proton pump inhibitors and clopidogrel on clinical outcome in patients after coronary stent implantation.
    Tentzeris I, Jarai R, Farhan S, Brozovic I, Smetana P, Geppert A, Wojta J, Siller-Matula J, Huber K.
    Thromb Haemost; 2010 Dec 07; 104(6):1211-8. PubMed ID: 20941464
    [Abstract] [Full Text] [Related]

  • 20. Point-of-care testing of clopidogrel-mediated platelet inhibition and risk for cardiovascular events after coronary angiography with or without percutaneous coronary intervention.
    Holm M, Dalén M, Tornvall P, van der Linden J.
    Blood Coagul Fibrinolysis; 2014 Sep 07; 25(6):577-84. PubMed ID: 24614428
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.